MICAFUNGIN
Generic: MICAFUNGIN
Biocon Pharma Inc.Manufacturer
INTRAVENOUSRoute
MICAFUNGIN SODIUMActive Substance
2024-05-29Original Approval
MICAFUNGIN is FDA application ANDA216438, sponsored by BIOCON PHARMA. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Top Reported Reactions
1
DRUG INEFFECTIVE
1,105 reports
2
OFF LABEL USE
691 reports
3
PYREXIA
487 reports
4
FEBRILE NEUTROPENIA
435 reports
5
PRODUCT USE IN UNAPPROVED INDICATION
320 reports
6
PNEUMONIA
313 reports
7
SEPSIS
308 reports
8
MULTIPLE ORGAN DYSFUNCTION SYNDROME
281 reports
9
DIARRHOEA
271 reports
10
NEUTROPENIA
264 reports